Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
4,214,831
-
Shares change
-
+638,119
-
Total reported value, excl. options
-
$204,391,820
-
Value change
-
+$32,481,115
-
Put/Call ratio
-
28%
-
Number of buys
-
43
-
Number of sells
-
-25
-
Price
-
$48.56
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2018
93 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q3 2018.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,214,831 shares
.
Largest 10 shareholders include MORGAN STANLEY (878,319 shares), GOLDMAN SACHS GROUP INC (466,124 shares), DEUTSCHE BANK AG\ (350,000 shares), HighTower Advisors, LLC (327,271 shares), BANK OF AMERICA CORP /DE/ (315,556 shares), WELLS FARGO & COMPANY/MN (240,980 shares), BNP PARIBAS ARBITRAGE, SA (200,000 shares), Baird Financial Group, Inc. (156,433 shares), LAZARD ASSET MANAGEMENT LLC (155,230 shares), and UBS Group AG (137,717 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.